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Silver nanoparticles (AgNPs) were successfully synthesized using silver nitrate via the biological route using the
culture filtrate of Ganoderma enigmaticum as well as Trametes ljubarskyi white rot fungi materials at room tem-
perature. The proposed synthetic technique was applied for the first time for AgNPs preparation via the biological
route through a low-cost pathway, which considered as an adequate direction of preparation compared to the
commercial methods. This study reports the in vitro cytotoxic effect of biologically synthesized AgNPs in
disposing of the human lung cancer cell line (A549) and human breast cancer cell (MCF-7) by using a 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. In addition, the viability of the tested
cell lines was tested after treatment for 24 h in the presence of the prepared nanoparticles. The obtained results
indicated the reduced viability of cancer cell lines with improving concentrations of AgNPs (40–120 μg/mL) at 24
h. Furthermore, at 120 μg/mL concentration, the fungal nanoparticles showed substantial cytotoxic effects toward
the treated cells. Consequently, the results designated that the biologically synthesized silver nanoparticles have
effective behavior for treating A549 and MCF-7 cancer cells from the laboratory experiment approach; however,
additional studies are required to validate these results in vivo models as anticancer agents depending on their
cytotoxic activity.1. Introduction
Nanobiotechnology as a branch of nanoscience can use several nano-
based systems for a diversity of biomedical applications, including
treatment pathways of human cancers [1, 2, 3, 4, 5]. Furthermore, the
reason for using nanoparticles for disease therapy depends on their
structure and dimension compared to the conventional small-molecule
medicines [6, 7, 8]. Amongst the metal nanoparticles, silver nano-
particles (AgNPs) are a good candidate for infection control owing to
their contact with the mitochondrial respiratory chain, which shows
compatibility and bioavailability toward the treatment of various
persistent illnesses, including cancer [9, 10, 11]. In addition, AgNPs have
the advantage of disrupting mitochondrial function with the aid ofm (G. Krishna), a.shalan133@gm
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vier Ltd. This is an open access arprompting the generation of reactive oxygen species and the advantage
of facilitating the preparation of ATP [12]. Metallic silver with ultrafine
particles in nanometer (nm) size have distinct morphologies and char-
acteristics that pave the way toward using it in different engineering
technologies [13, 14]. Moreover, the purpose of using AgNPs for nano-
medicine applications may come from their special features and clear
therapeutic prospects in considering a range of diseases, such as retinal
neovascularization as well as developed immunodeficiency syndrome
because of the human immunodeficiency virus [15, 16, 17, 18]. Addi-
tionally, the antimicrobial perspective of AgNPs against numerous other
viruses, such as hepatitis B, respiratory syncytial virus, and herpes sim-
plex virus type make AgNPs possess intrinsic cytotoxic action toward
diseases [19]. Currently, cancer is a leading cause of death across theail.com (A.E. Shalan).
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Figure 1. Cytotoxic effect of AgNPs based on G. enigmaticum against A549 cell line. The values are given as a mean  SD of three experiments in each group.
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treating numerous kinds of cancer cells [20]. Consequently, chemo-
therapy involving the use of cytotoxic agents is the further most normally
applied treatment to handle several kinds of cancer cells [21]. Alterna-
tively, these therapeutic methods are related to serious side-effect results,
particularly multidrug resistance (MDR). Therefore, to overcome the
undesirable side effects results of chemotherapy, numerous medically
associated nanoparticles like those that AgNPs were considered alone orFigure 2. Cytotoxic activity of AgNPs based on G. enigmaticum against A549 cell lin
2
in blend owing to their in vitro cytotoxicity aspect for drug therapy and
radiation treatment [22]. Further, several researches have been accom-
plished to use silver nanoparticles as an anti-cancer agent, and they have
all shown positive results, which paves the way for different new di-
rections in the field of medication [23]. To the best of our knowledge,
only a few studies on the effect of biosynthesized AgNPs toward tumor
control via their cytotoxic effects. One research work detected the anti-
proliferative activity of AgNPs against different cancer cells including thee at different concentrations (a) control, (b) 80 μg, (c) 100 μg and (d) 120 μg.
Table 1. Effect of different concentrations of the synthesized AgNPs based on
G. enigmaticum for treating A549 cell line through the MTT assay.
Concentration (μg/ml) A549 Cell Line
% Cell viability % Cell inhibition
120 15.64  0.10 84.36
100 25.36  0.04 74.64
80 32.72  0.3 67.28
60 44.28  0.3 55.72
40 60.65  0.03 39.35
Control 100 0
Table 2. Effect of different concentrations of the synthesized AgNPs based on
G. enigmaticum for treating MCF-7 cell line through the MTT assay.
Concentration (μg/ml) MCF-7 Cell Line
% Cell viability % Cell inhibition
120 24.36  0.04 75.64
100 31.72  0.3 68.28
80 44.28  0.3 55.72
60 54.89 þ 0.04 45.14
40 60.65  0.03 39.35
Control 100 0
G. Krishna et al. Heliyon 7 (2021) e06470human lung cancer cell line (A549) and human breast cancer cell lines
(MCF-7) & (HTB-22) and showed inhibition of tumor cells, especially in
the case of A549 and MCF-7 cells [24]. Another study assessed the silver
nanoparticles synthesized from different biological sources such as
Penicillium brevicompactum, Trichoderma viride, and Croton Bonplandianum
and indicated their potent cytotoxicity against different cancer cells via
MTT assay through in vitro analysis. Silver nanoparticles showed
promising effects on cancer cells up to a certain concentration. Using
different concentrations of nanoparticles, the IC50 value showed
different values of (% cell viability) and (% cell inhibition) for the
different cells’ lines depending on the time of incubation [25, 26, 27].
There are several biological bases of AgNPs synthesis, and the difference
between the current prepared materials compared to the others is the
source of the biological route [28, 29, 30, 31, 32]. Here, the difference
between the current work and previous ones is that we intended to
prepare AgNPs via the biological route using Ganoderma enigmaticum as





















Figure 3. Cytotoxic effect of AgNPs based on G. enigmaticum against MCF-7 cell li
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synthetic pathway is used for the first time to prepare AgNPs via the
biological route in a low-cost approach; this is considered to be an
adequate direction compared to the commercial and conventional
methods. Thus, the current study intended to estimate the anti-cancer
influence of the biologically attained AgNPs depending on their cyto-
toxic activity.
2. Experimental section
2.1. Material and methods
2.1.1. Chemicals
All the required chemicals were bought from HiMedia (India).
Furthermore, distilled water was used during the proposed experiments.
2.1.2. Collection and molecular identification of white rot fungi
Fungi, in the form of fruiting bodies, were obtained and sterilized
with ethyl alcohol disinfectants, and approximately 3 3 mmwas placed
on Malt extract agar medium in slants. After the growth of mycelium, it
was transferred into the slants. This was repeatedly conducted until pure
culture was obtained. Molecular identification on ribo-typing of 18S
rRNA was conducted at Eurofins Laboratories Bangalore, India, and the
sequence was deposited in the NCBI database for the accession number.
2.1.3. Preparation of silver nanoparticles (AgNPs)
In order to synthesize silver nanoparticles (AgNPs), T. ljubarskyi and
G. enigmaticum were developed aerobically in liquid medium containing
glucose, 15.0 gm; KH2PO4, 7.0 gm; K2HPO4, 2.0 gm; (NH2)SO4, 1.0 gm;
MgSO4⋅7H2O, 0.1 gm; and yeast extract, 1.0 gm. Furthermore, the
Erlenmeyer flasks were protected with the fungal culture and were
incubated on an incubator shaker at 30 C (120 rpm). Then, the collec-
tion of biomasses was completed after 3 days through filtration using a
filter paper (Whatman No. 1). Additionally, the culture filtrate was tested
with an equal amount of 1 mm silver nitrate solution, which is arranged
in deionized water and incubated at 32 C (120 rpm). Finally, the control
samples were obtained using the filtrates without silver ions. In addition,
all the prepared and used materials were purified to avoid any kind of
toxicity. For the reproducibility course, all the experimental tests were
checked in triplicate to confirm the obtained results.
2.1.4. Investigation of anticancer activity
The cytotoxicity potential of compounds was tested on human breast
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Figure 4. Cytotoxic activity of AgNPs based on G. enigmaticum against MCF-7 cell line at different concentrations (a) control, (b) 80 μg, (c) 100 μg and (d) 120 μg.
Figure 5. Cytotoxic effect of AgNPs based on T. ljubarskyi against A549 cell line. The values are given as mean  SD of three experiments in each group.
G. Krishna et al. Heliyon 7 (2021) e06470cell proliferation assay [33]. Human breast carcinoma and lung carci-
noma cell lines were achieved from the National Center for Cell Science
(NCCS), Pune (India), and cultivated in Dulbecco's modified Eagle's red
medium (DMEM) (Sigma Life Science, USA) containing 10% fetal bovine
serum (FBS). Additionally, yellow-coloredMTT is transformed into a blue
formazan invention via metabolically active mitochondria, and the
absorbance is straight proportional to the number of viable cells.
Thereafter, A549, HeLa, and MCF-7 cells were plated in 96-well4
flat-bottom tissue culture plates at the density of approximately 1.2 
104 cells/well and allowed to ascribe overnight at 37 C. In addition,
AgNPs with altered concentration were added to the medium to discard it
and to enable the incubation of the cells, and the process was continued
for 24 h. Consequently, the medium was discarded after the incubation
process, and 100 μL fresh medium was added to 10-μL MTT (5 mg/mL).
Additionally, 4 h later, the medium was discarded again and another
100-μL DMSOwas added to dissolve the formazan crystals. We found that
Figure 6. Cytotoxic effect of AgNPs based on T. ljubarskyi against MCF-7 cell line. The values are given as mean  SD of three experiments in each group.
G. Krishna et al. Heliyon 7 (2021) e06470the absorbance was checked at 570 nm in a microliter plate
reader. Finally, cell survival was calculated via the following Eqs. (1) and
(2):
Viability % ¼ (Test OD/Control OD) x 100 (1)
Cytotoxicity % ¼ 100 – Viability% (2)Figure 7. Cytotoxic activity of AgNPs based on T. ljubarskyi against A549 cell line
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2.1.5. Principle of cell viability detection
With the same procedure as discussed in our previous related studies,
NAD-dependent mitochondrial dehydrogenase of viable cells is used to
cleave the MTT (3-(4, 5-dimethyl thiazol-2yl)2, 5-diphenyl tetrazolium
bromide) to form a quantifiable purple formazan product [34, 35, 36, 37,at different concentrations (a) control, (b) 80 μg, (c) 100 μg and (d) 120 μg.
Table 3. Effect of different concentrations of the synthesized AgNPs based on T.
ljubarskyi for treating A549 cell line through the MTT assay.
Concentration (μg/ml) A549 Cell Line
% Cell viability % Cell inhibition
120 20.64  0.04 79.36
100 27.36  0.04 72.64
80 31.72  0.3 68.28
60 45.28  0.3 54.72
40 66.68  0.03 33.32
Control 100 0
Table 4. Effect of different concentrations of the synthesized AgNPs based on T.
ljubarskyi for treating MCF7 cell line through the MTT assay.
Concentration (μg/ml) MCF-7 Cell Line
% Cell viability % Cell inhibition
120 16.64  0.10 83.36
100 28.36  0.04 71.64
80 32.72  0.3 71.64
60 54.86  0.3 67.28
40 66.68  0.03 33.32
Control 100 0
Figure 8. Cytotoxic activity of AgNPs based on T. ljubarskyi against MCF-7 cell line at different concentrations (a) control, (b) 80 μg, (c) 100 μg and (d) 120 μg.
G. Krishna et al. Heliyon 7 (2021) e0647038]. We can observe the proportional relationship between the attained
formazan production and viable cell number.
3. Results and discussion
3.1. The cytotoxicity effect of silver nanoparticles (AgNPs) based on
G. enigmaticum through the MTT assay
To check the cytotoxic effect of the biosynthesized silver nano-
particles on tumors, the cytotoxic activity of the attained silver nano-
particles based on G. enigmaticum was detected (in vitro) and considered
at different concentrations against human lung cancer (A549) and human
breast cancer cell lines (MCF7). We observed that the prepared AgNPs
demonstrated a strong cytotoxicity effect for the tested cell lines in
comparison with the untreated cells. Furthermore, the acquired results
indicated that higher cell mortality occurs at higher concentrations of the
used nanoparticles. To check the inhibition effect, the reaction was kept
and incubated for 24 h (Figure 1). displays the variations in the6
percentage of inhibition in nanoparticles that is used to treat (A549) lung
cancer cells. In addition, the cytotoxicity activity effect of G. enigmaticum-
AgNPs materials against (A549) cells were detected by treatment of
different concentrations of the prepared nanoparticles (Control, 80, 100
and 120 μg/mL) to check the inhibition of the tumor cells (as illustrated
in Figure 2). The results indicated that the maximum cell growth inhi-
bition (84.36%) was perceived for the sample with a concentration of
120 μg/mL (Figure 1). Additionally, the dose-dependent approach (MTT
assay) on A549 cells after treatment with altered concentrations of the
prepared silver nanoparticles of G. enigmaticum is shown in Table 1. The
results showed a relationship between the (% cell viability) and (% cell
inhibition) for A549 cell lines with the concentration of the used nano-
particles. As the concentration of the nanoparticles decreased, the
viability of the A549 cell lines dose-dependently reduced (Table 1). The
detected decrease in cell viability indicates the anticancer properties of
AgNPs [39].
Similarly, the same sequence of measurements was performed for the
(MCF-7) cancer cell lines using AgNPs based on G. enigmaticum in vitro,
G. Krishna et al. Heliyon 7 (2021) e06470and the results specified that, the reaction was incubated for 24 h to
check the inhibitory effect. The MTT assay on MCF-7 cancer cells after
treatment with different concentrations of the prepared silver nano-
particles based on G. enigmaticum is found in Table 2. The results show
that there is a relation between the % cell viability and % cell inhibition
for the MCF-7 cancer cell lines with the concentration of the used
nanoparticles [40]. As the concentration of the nanoparticles decreased,
the viability of the (MCF-7) cells dose-dependently reduced (Table 2).
Furthermore (Figure 3), displays the variations in the percentage of in-
hibition in nanoparticles that is used to treat MCF-7 breast cancer cells. In
addition, the cytotoxicity activity effect of AgNPs materials based on
G. enigmaticum against MCF-7 cells was detected via the treatment of
different concentrations of the prepared nanoparticles (Control, 80, 100,
and 120 μg/mL) to check the inhibition of the tumor cells (as illustrated
in Figure 4). The results indicated that the maximum cell growth inhi-
bition (75.64%) was perceived for the sample with a concentration of
120 μg/mL (Figure 3). Additionally, no cytotoxicity was detected against
standard untreated cells [41]. The result of the prepared silver nano-
particles was the same as obtained in our previous research work, and it
shows that the gained particles were spherical in shape with particle size
distribution of 5–40 nm [42, 43].
3.2. The cytotoxicity effect of silver nanoparticles (AgNPs) based on T.
ljubarskyi through the MTT assay
To detect the cytotoxic effect of the prepared nanoparticles on the
tumors, the cytotoxic activity of the attained AgNPs based on T. ljubarskyi
was distinguished (in vitro) at different concentrations, and reflected the
effect in contradiction of (A549) as well as (MCF7) cancer cells. The
variations in the inhibition percentage in nanoparticles that are used to
treat (A549) lung cancer cells and breast cancer cells (MCF7) are dis-
played in Figure 5 and Figure 6, respectively. In addition, the cytotoxicity
activity effect of AgNPs based on T. ljubarskyi against both (A549) lung as
well as (MCF7) cancer cells was detected through the treatment of
different concentrations of the prepared nanoparticles (control, 80, 100,
and 120 μg/mL) to check the inhibition of tumor cells as illustrated in
Figures 7 and 8, respectively. Further, the MTT assay on A549 and MCF7
cells after treatment with different concentrations of the prepared silver
nanoparticles based on T. ljubarskyi is found in Table 3 & Table 4,
respectively. The results show that there is a relationship between the %
cell viability and% cell inhibition for both A549 andMCF7 cell lines with
the concentration of the used nanoparticles [44]. Hence, from the ob-
tained results in the cases, the prepared nanoparticle materials were
found to be effectively potent against lung and breast cancer cell lines.
AgNPs based on G. enigmaticum showed more potency against the A549
cell line compared to the effect gained against MCF-7. Additionally, in
case of AgNPs based on T. ljubarskyi, the opposite effect was obtained as
the effect on MCF7 cell line was better than the effect obtained against
A549 cell line.
The dose-dependent method (MTT assay) was used for the evaluation
of the toxicity gained from the attained nanoparticles on both A549 and
MCF-7. The mortality data obtained confirmed that the biosynthesized
AgNPs materials attained via the white rot fungus sources (G. enigmati-
cum & T. ljubarskyi) have potential anticancer activity [45, 46, 47].
Conversely, besides the effect of prepared nanoparticles on cell
viability, we can recognize that the obtained silver nanoparticles may
have another effect, which called “nanomaterial induced endothelial
cells leakiness” (NanoEL). This effect can be produced via inducing
endothelial leakiness in endothelial cells. Different studies gave a wide
description of the phenomenon, and based on their studies, we can
conclude that changing the nanoscale dimensions of the prepared silver
nanoparticles facilitates the movement of these nanoparticles inside the
nanosized gaps between microvascular capillary endothelial cells and
dislocated the protein connections that embrace neighboring cells. We
can confirm that the NanoEL effect of the prepared nanoparticles has
momentous implications toward nanomedicine and nanotoxicology. In7
addition, we can similarly predict the mechanism that explicates the
silver nanoparticles connection with the cells characteristic state of ab-
sorptivity resistance [48, 49, 50].
4. Conclusion
The anticancer activity of the biosynthesized silver nanoparticles
(AgNPs) materials using two white rot fungi (G. enigmaticum & T. lju-
barskyi) displayed extensive cytotoxic effects in contradiction of different
human cancer cell lines (A549) and (MCF7) cancer cells. The difference
between the current work and previous ones was that we intended to
prepare AgNPs via the biological route using white rot fungus materials.
The proposed synthetic pathway is used for the first time to prepare
AgNPs via the biological route through a low-cost pathway, which
considered as an adequate direction of preparation compared to the
commercial methods. As a result, the prepared AgNPs is considered as
active anticancer agents. The dose-dependent method (MTT assay) was
used for the evaluation of the toxicity gained from the attained nano-
particles on both A549 and MCF-7. The mortality data acquired confirm
that the biosynthesized AgNPs materials attained via the white rot fungus
sources (G. enigmaticum & T. ljubarskyi) have potential anticancer activ-
ity. However, an exhaustive study concerning the relations of microbial
prepared AgNPs with cancer cell lines is required before their use in
medical applications. In this regard, additional cytotoxicity studies and
animal trials must be conducted before the product enters the market.
Declarations
Author contribution statement
Gudikandula Krishna: Conceived and designed the experiments;
Contributed reagents, materials, analysis tools or data; Wrote the paper.
V. Srileka: Performed the experiments; Analyzed and interpreted the
data.
M. A. Singara Charya: Analyzed and interpreted the data; Contributed
reagents, materials, analysis tools or data.
Esraa Samy Abu Serea: Analyzed and interpreted the data; Wrote the
paper.
Ahmed Esmail Shalan: Conceived and designed the experiments;
Analyzed and interpreted the data; Wrote the paper.Funding statement
This research did not receive any specific grant from funding agencies
in the public, commercial, or not-for-profit sectors.Data availability statement
Data included in article/supplementary material/referenced in
article.Declaration of interests statement
The authors declare no conflict of interest.Additional information
No additional information is available for this paper.
Acknowledgements
Kakatiya University, India, and CMRDI, Egypt, are appreciated by the
authors for their assistance in following up this study.
G. Krishna et al. Heliyon 7 (2021) e06470References
[1] H.J. Burstein, G. Curigliano, S. Loibl, P. Dubsky, M. Gnant, P. Poortmans,
M. Colleoni, C. Denkert, M. Piccart-Gebhart, M. Regan, H.J. Senn, Estimating the
benefits of therapy for early-stage breast cancer: the St. Gallen International
Consensus Guidelines for the primary therapy of early breast cancer 2019, Ann.
Oncol. 30 (2019) 1541–1557.
[2] S.’D. DeVeaux, C.T. Gomillion, Assessing the potential of chitosan/polylactide
nanoparticles for delivery of therapeutics for triple-negative breast cancer
treatment, Regener. Eng. Transl. Med. 5 (2019) 61–73.
[3] Y. Li, Y. Xiao, H.P. Lin, D. Reichel, Y. Bae, E.Y. Lee, Y. Jiang, X. Huang, C. Yang,
Z. Wang, In vivo β-catenin attenuation by the integrin α5-targeting nano-delivery
strategy suppresses triple negative breast cancer stemness and metastasis,
Biomaterial 188 (2019) 160–172.
[4] R.L. Siegel, K.D. Miller, A. Jemal, Cancer statistics, 2019, Ca - Cancer J. Clin. 69
(2019) 7–34.
[5] M.F. Sanad, A.E. Shalan, S.M. Bazid, E.S. Serea, E.M. Hashem, S. Nabih, M.A. Ahsan,
A graphene gold nanocomposite-based 5-FU drug and the enhancement of the MCF-
7 cell line treatment, RSC Adv. 9 (2019) 31021–31029.
[6] T.A. Brocato, E.N. Coker, P.N. Durfee, Y.S. Lin, J. Townson, E.F. Wyckoff, V. Cristini,
C.J. Brinker, Z. Wang, Understanding the connection between nanoparticle uptake
and cancer treatment efficacy using mathematical modeling, Sci. Rep. 8 (2018)
7538.
[7] W. Wang, L. Lin, X. Ma, B. Wang, S. Liu, X. Yan, S. Li, H. Tian, X. Yu, Light-induced
hypoxia-triggered living nanocarriers for synergistic cancer therapy, ACS Appl.
Mater. Interfaces 10 (2018) 19398–19407.
[8] R. Girgin, N.A. Mungan, Organ-preserving approach in bladder cancer: assessment
of the current situation, Bulletin Urooncology 17 (2018) 63.
[9] A. Aygün, F. Gülbagça, M.S. Nas, M.H. Alma, M.H. Çalımlı, B. Ustaoglu,
Y.C. Altunoglu, M.C. Baloglu, K. Cellat, F. Şen, Biological synthesis of silver
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